Alphatec Holdings, Inc. (NASDAQ:ATEC) announced preliminary financial results for Q4 and provided guidance for fiscal 2023 revenue and adjusted EBITDA. While numbers came in better than expected, shares fell more than 5% today.
For Q4, the company expects revenue to be in the range of $105.2-106.2 million (up 42-44% year-over-year), well above the Street estimate of $95.3 million. This includes Surgical revenue of $90.7-91.5 million (up 48-50% year-over-year), compared to the Street estimate of $83.5 million and EOS revenue of $14.5-14.7 million (up 13-15% year-over-year), compared to the Street estimate of $13.0 million.
For 2023, the company expects revenue to be $438 million (up 25% year-over-year), above the Street estimate of $412 million. Further, management reiterated expectations for reaching adjusted EBITDA breakeven in 2023.